Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SANUWAVE Health (SNWV) Research & Development (2023 - 2025)

SANUWAVE Health (SNWV) has disclosed Research & Development for 9 consecutive years, with $606000.0 as the latest value for Q4 2025.

  • Quarterly Research & Development rose 293.51% to $606000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.4 million through Dec 2025, up 101.04% year-over-year, with the annual reading at $1.4 million for FY2025, 101.04% up from the prior year.
  • Research & Development for Q4 2025 was $606000.0 at SANUWAVE Health, up from $345000.0 in the prior quarter.
  • The five-year high for Research & Development was $606000.0 in Q4 2025, with the low at $139000.0 in Q2 2023.
  • Average Research & Development over 3 years is $224818.2, with a median of $165000.0 recorded in 2023.
  • The sharpest move saw Research & Development dropped 2.42% in 2024, then skyrocketed 293.51% in 2025.
  • Over 3 years, Research & Development stood at $143000.0 in 2023, then grew by 7.69% to $154000.0 in 2024, then surged by 293.51% to $606000.0 in 2025.
  • According to Business Quant data, Research & Development over the past three periods came in at $606000.0, $345000.0, and $194000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.